Srinivas Akkaraju - Jul 26, 2022 Form 3 Insider Report for Scholar Rock Holding Corp (SRRK)

Role
Director
Signature
/s/ Junlin Ho, Attorney-in-Fact for Srinivas Akkaraju
Stock symbol
SRRK
Transactions as of
Jul 26, 2022
Transactions value $
$0
Form type
3
Date filed
7/28/2022, 05:02 PM
Previous filing
Jun 2, 2022
Next filing
Apr 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SRRK Common Stock 4.6M Jul 26, 2022 By Fund F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SRRK Warrants to purchase Common Stock Jul 26, 2022 Common Stock 1.06M $7.35 By Fund F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Samsara BioCapital LP ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the shares held by Samsara LP. Dr. Srinivas Akkaraju, MD, Ph.D. has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Each of Samsara LLC and Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his or its respective pecuniary interest therein.
F2 The warrants are exercisable subject to a beneficial ownership blocker provision that prevents the holder from exercising the warrants if such exercise would result in the holder beneficially owning more than 19.99% of the Issuer's Common Stock outstanding immediately following such exercise.